JP2018506534A5 - - Google Patents

Download PDF

Info

Publication number
JP2018506534A5
JP2018506534A5 JP2017541934A JP2017541934A JP2018506534A5 JP 2018506534 A5 JP2018506534 A5 JP 2018506534A5 JP 2017541934 A JP2017541934 A JP 2017541934A JP 2017541934 A JP2017541934 A JP 2017541934A JP 2018506534 A5 JP2018506534 A5 JP 2018506534A5
Authority
JP
Japan
Prior art keywords
ghr
stat5
socs
halogen
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017541934A
Other languages
English (en)
Japanese (ja)
Other versions
JP6930916B2 (ja
JP2018506534A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/017717 external-priority patent/WO2016130901A2/en
Publication of JP2018506534A publication Critical patent/JP2018506534A/ja
Publication of JP2018506534A5 publication Critical patent/JP2018506534A5/ja
Application granted granted Critical
Publication of JP6930916B2 publication Critical patent/JP6930916B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017541934A 2015-02-12 2016-02-12 疾患予防および治療における成長ホルモン受容体の遮断剤 Active JP6930916B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562115356P 2015-02-12 2015-02-12
US62/115,356 2015-02-12
PCT/US2016/017717 WO2016130901A2 (en) 2015-02-12 2016-02-12 Blockers of the growth hormone receptor in disease prevention and treatment

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021018032A Division JP2021075553A (ja) 2015-02-12 2021-02-08 疾患予防および治療における成長ホルモン受容体の遮断剤

Publications (3)

Publication Number Publication Date
JP2018506534A JP2018506534A (ja) 2018-03-08
JP2018506534A5 true JP2018506534A5 (enExample) 2019-03-28
JP6930916B2 JP6930916B2 (ja) 2021-09-01

Family

ID=56615057

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017541934A Active JP6930916B2 (ja) 2015-02-12 2016-02-12 疾患予防および治療における成長ホルモン受容体の遮断剤
JP2021018032A Pending JP2021075553A (ja) 2015-02-12 2021-02-08 疾患予防および治療における成長ホルモン受容体の遮断剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021018032A Pending JP2021075553A (ja) 2015-02-12 2021-02-08 疾患予防および治療における成長ホルモン受容体の遮断剤

Country Status (14)

Country Link
US (2) US10246446B2 (enExample)
EP (1) EP3256465B1 (enExample)
JP (2) JP6930916B2 (enExample)
KR (1) KR20180016333A (enExample)
CN (1) CN107438605B (enExample)
AU (1) AU2016219173B2 (enExample)
BR (1) BR112017017182A2 (enExample)
CA (1) CA2976219C (enExample)
ES (1) ES2871551T3 (enExample)
IL (1) IL253943A0 (enExample)
MX (1) MX383010B (enExample)
NZ (1) NZ734252A (enExample)
RU (1) RU2726254C2 (enExample)
WO (1) WO2016130901A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
MX2020009613A (es) 2018-03-15 2021-02-26 Univ Southern California Dieta que imita el ayuno (fmd) pero no ayuno solo con agua, promueve la reversion de la inflamacion y patologia de la enfermedad de intestino irritable (ibd).
CN120865406A (zh) * 2024-04-30 2025-10-31 长春金赛药业有限责任公司 Ghr激动型抗体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701010D0 (sv) * 1997-03-19 1997-03-19 Pharmacia & Upjohn Ab Antibody
US20040204368A1 (en) 2001-05-31 2004-10-14 Kazuyuki Ohmoto Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
WO2006001770A1 (en) * 2004-06-28 2006-01-05 Biovitrum Ab Method for identifying modulators of cytokine class i receptor
RU2415134C9 (ru) * 2005-08-15 2011-05-27 Этерна Центарис ГмбХ Способ лечения или профилактики физиологических и/или патофизиологических состояний, опосредуемых рецепторами, стимулирующими секрецию гормона роста, триазолы и фармацевтическая композиция на их основе
CA2701946A1 (en) * 2007-10-11 2009-04-16 Vertex Pharmaceuticals Incorporated Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
PT2993186T (pt) * 2008-03-14 2019-11-29 Biocon Ltd Anticorpo monoclonal e um método do mesmo
WO2011013039A1 (en) * 2009-07-28 2011-02-03 Koninklijke Philips Electronics N.V. Housing with locking structure
RU2014123030A (ru) * 2011-12-22 2016-02-20 Ринат Ньюросайенс Корп. Антагонистические антитела против человеческого рецептора гормона роста и способы их применения
WO2013123511A1 (en) * 2012-02-16 2013-08-22 New York University Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics
US9732067B2 (en) * 2012-06-20 2017-08-15 University Of Kansas Compounds and methods for activating the apoptotic arm of the unfolded protein response
CA2900782C (en) 2013-02-12 2022-09-27 University Of Southern California Methods and diets to protect against chemotoxicity and age related illnesses

Similar Documents

Publication Publication Date Title
JP2016040288A5 (enExample)
JP2016505637A5 (enExample)
JP2020097577A5 (enExample)
JP2016528301A5 (enExample)
JP2015524472A5 (enExample)
JP2016515561A5 (enExample)
JP2016503797A5 (enExample)
JP2017511377A5 (enExample)
JP2016536286A5 (enExample)
JP2017528503A5 (enExample)
JP2019515908A5 (enExample)
JP2014528464A5 (enExample)
RU2017114346A (ru) АНТАГОНИСТЫ ИНТЕГРИНА ανβ6
JP2016508134A5 (enExample)
JP2012513416A5 (enExample)
JP2013518107A5 (enExample)
JP2020507589A5 (enExample)
JP2014505107A5 (enExample)
JP2012255002A5 (enExample)
JP2016515628A5 (enExample)
RU2015126015A (ru) Новые улавливатели в лечении макулодистрофии
JP2019520344A5 (enExample)
JP2019535723A5 (enExample)
JP2015521156A5 (enExample)
JP2010521516A5 (enExample)